Guidelines for mass screening of congenital hypothyroidism (2014 revision)

Keisuke Nagasaki, Kanshi Minamitani, Makoto Anzo, Masanori Adachi, Tomohiro Ishii, Kazumichi Onigata, Satoshi Kusuda, Shohei Harada, Reiko Horikawa, Masanori Minagawa, Haruo Mizuno, Yuji Yamakami, Masaru Fukushi, Toshihiro Tajima

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose of developing the guidelines: Mass screening for congenital hypothyroidism started in 1979 in Japan, and the prognosis for intelligence has been improved by early diagnosis and treatment. The incidence was about 1/4000 of the birth population, but it has increased due to diagnosis of subclinical congenital hypothyroidism. The disease requires continuous treatment, and specialized medical facilities should make a differential diagnosis and treat subjects who are positive in mass screening to avoid unnecessary treatment. The Guidelines for Mass Screening of Congenital Hypothyroidism (1998 version) were developed by the Mass Screening Committee of the Japanese Society for Pediatric Endocrinology in 1998. Subsequently, new findings on prognosis and problems in the adult phase have emerged. Based on these new findings, the 1998 guidelines were revised in the current document (hereinafter referred to as the Guidelines). Target disease/conditions: Primary congenital hypothyroidism. Users of the Guidelines: Physician specialists in pediatric endocrinology, pediatric specialists, physicians referring patients to pediatric practitioners, general physicians, laboratory technicians in charge of mass screening, and patients.

Original languageEnglish
Pages (from-to)107-133
Number of pages27
JournalClinical Pediatric Endocrinology
Volume24
Issue number3
Publication statusPublished - 2015 Jul 18

Fingerprint

Congenital Hypothyroidism
Mass Screening
Guidelines
Pediatrics
Endocrinology
Physicians
Laboratory Personnel
Intelligence
General Practitioners
Early Diagnosis
Japan
Differential Diagnosis
Therapeutics
Parturition
Incidence
Population

Keywords

  • Congenital hypothyroidism
  • Guideline
  • Mass screening

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Pediatrics, Perinatology, and Child Health

Cite this

Nagasaki, K., Minamitani, K., Anzo, M., Adachi, M., Ishii, T., Onigata, K., ... Tajima, T. (2015). Guidelines for mass screening of congenital hypothyroidism (2014 revision). Clinical Pediatric Endocrinology, 24(3), 107-133.

Guidelines for mass screening of congenital hypothyroidism (2014 revision). / Nagasaki, Keisuke; Minamitani, Kanshi; Anzo, Makoto; Adachi, Masanori; Ishii, Tomohiro; Onigata, Kazumichi; Kusuda, Satoshi; Harada, Shohei; Horikawa, Reiko; Minagawa, Masanori; Mizuno, Haruo; Yamakami, Yuji; Fukushi, Masaru; Tajima, Toshihiro.

In: Clinical Pediatric Endocrinology, Vol. 24, No. 3, 18.07.2015, p. 107-133.

Research output: Contribution to journalArticle

Nagasaki, K, Minamitani, K, Anzo, M, Adachi, M, Ishii, T, Onigata, K, Kusuda, S, Harada, S, Horikawa, R, Minagawa, M, Mizuno, H, Yamakami, Y, Fukushi, M & Tajima, T 2015, 'Guidelines for mass screening of congenital hypothyroidism (2014 revision)', Clinical Pediatric Endocrinology, vol. 24, no. 3, pp. 107-133.
Nagasaki K, Minamitani K, Anzo M, Adachi M, Ishii T, Onigata K et al. Guidelines for mass screening of congenital hypothyroidism (2014 revision). Clinical Pediatric Endocrinology. 2015 Jul 18;24(3):107-133.
Nagasaki, Keisuke ; Minamitani, Kanshi ; Anzo, Makoto ; Adachi, Masanori ; Ishii, Tomohiro ; Onigata, Kazumichi ; Kusuda, Satoshi ; Harada, Shohei ; Horikawa, Reiko ; Minagawa, Masanori ; Mizuno, Haruo ; Yamakami, Yuji ; Fukushi, Masaru ; Tajima, Toshihiro. / Guidelines for mass screening of congenital hypothyroidism (2014 revision). In: Clinical Pediatric Endocrinology. 2015 ; Vol. 24, No. 3. pp. 107-133.
@article{475bcb52e84841b98339dc080f47e9ea,
title = "Guidelines for mass screening of congenital hypothyroidism (2014 revision)",
abstract = "Purpose of developing the guidelines: Mass screening for congenital hypothyroidism started in 1979 in Japan, and the prognosis for intelligence has been improved by early diagnosis and treatment. The incidence was about 1/4000 of the birth population, but it has increased due to diagnosis of subclinical congenital hypothyroidism. The disease requires continuous treatment, and specialized medical facilities should make a differential diagnosis and treat subjects who are positive in mass screening to avoid unnecessary treatment. The Guidelines for Mass Screening of Congenital Hypothyroidism (1998 version) were developed by the Mass Screening Committee of the Japanese Society for Pediatric Endocrinology in 1998. Subsequently, new findings on prognosis and problems in the adult phase have emerged. Based on these new findings, the 1998 guidelines were revised in the current document (hereinafter referred to as the Guidelines). Target disease/conditions: Primary congenital hypothyroidism. Users of the Guidelines: Physician specialists in pediatric endocrinology, pediatric specialists, physicians referring patients to pediatric practitioners, general physicians, laboratory technicians in charge of mass screening, and patients.",
keywords = "Congenital hypothyroidism, Guideline, Mass screening",
author = "Keisuke Nagasaki and Kanshi Minamitani and Makoto Anzo and Masanori Adachi and Tomohiro Ishii and Kazumichi Onigata and Satoshi Kusuda and Shohei Harada and Reiko Horikawa and Masanori Minagawa and Haruo Mizuno and Yuji Yamakami and Masaru Fukushi and Toshihiro Tajima",
year = "2015",
month = "7",
day = "18",
language = "English",
volume = "24",
pages = "107--133",
journal = "Clinical Pediatric Endocrinology",
issn = "0918-5739",
publisher = "Jeff Corporation Co. Ltd",
number = "3",

}

TY - JOUR

T1 - Guidelines for mass screening of congenital hypothyroidism (2014 revision)

AU - Nagasaki, Keisuke

AU - Minamitani, Kanshi

AU - Anzo, Makoto

AU - Adachi, Masanori

AU - Ishii, Tomohiro

AU - Onigata, Kazumichi

AU - Kusuda, Satoshi

AU - Harada, Shohei

AU - Horikawa, Reiko

AU - Minagawa, Masanori

AU - Mizuno, Haruo

AU - Yamakami, Yuji

AU - Fukushi, Masaru

AU - Tajima, Toshihiro

PY - 2015/7/18

Y1 - 2015/7/18

N2 - Purpose of developing the guidelines: Mass screening for congenital hypothyroidism started in 1979 in Japan, and the prognosis for intelligence has been improved by early diagnosis and treatment. The incidence was about 1/4000 of the birth population, but it has increased due to diagnosis of subclinical congenital hypothyroidism. The disease requires continuous treatment, and specialized medical facilities should make a differential diagnosis and treat subjects who are positive in mass screening to avoid unnecessary treatment. The Guidelines for Mass Screening of Congenital Hypothyroidism (1998 version) were developed by the Mass Screening Committee of the Japanese Society for Pediatric Endocrinology in 1998. Subsequently, new findings on prognosis and problems in the adult phase have emerged. Based on these new findings, the 1998 guidelines were revised in the current document (hereinafter referred to as the Guidelines). Target disease/conditions: Primary congenital hypothyroidism. Users of the Guidelines: Physician specialists in pediatric endocrinology, pediatric specialists, physicians referring patients to pediatric practitioners, general physicians, laboratory technicians in charge of mass screening, and patients.

AB - Purpose of developing the guidelines: Mass screening for congenital hypothyroidism started in 1979 in Japan, and the prognosis for intelligence has been improved by early diagnosis and treatment. The incidence was about 1/4000 of the birth population, but it has increased due to diagnosis of subclinical congenital hypothyroidism. The disease requires continuous treatment, and specialized medical facilities should make a differential diagnosis and treat subjects who are positive in mass screening to avoid unnecessary treatment. The Guidelines for Mass Screening of Congenital Hypothyroidism (1998 version) were developed by the Mass Screening Committee of the Japanese Society for Pediatric Endocrinology in 1998. Subsequently, new findings on prognosis and problems in the adult phase have emerged. Based on these new findings, the 1998 guidelines were revised in the current document (hereinafter referred to as the Guidelines). Target disease/conditions: Primary congenital hypothyroidism. Users of the Guidelines: Physician specialists in pediatric endocrinology, pediatric specialists, physicians referring patients to pediatric practitioners, general physicians, laboratory technicians in charge of mass screening, and patients.

KW - Congenital hypothyroidism

KW - Guideline

KW - Mass screening

UR - http://www.scopus.com/inward/record.url?scp=84937831450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84937831450&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84937831450

VL - 24

SP - 107

EP - 133

JO - Clinical Pediatric Endocrinology

JF - Clinical Pediatric Endocrinology

SN - 0918-5739

IS - 3

ER -